A trial to evaluate the oral disposition of two compounds belonging to the biopharmaceutical Classification System Class II, fenofibrate (bile salt dependent solubility) and posaconazole (gastric pH dependent dissolution), before and after RYGB in the same individuals.

Trial Profile

A trial to evaluate the oral disposition of two compounds belonging to the biopharmaceutical Classification System Class II, fenofibrate (bile salt dependent solubility) and posaconazole (gastric pH dependent dissolution), before and after RYGB in the same individuals.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs Fenofibrate (Primary) ; Posaconazole (Primary)
  • Indications Aspergillosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Jul 2016 New trial record
    • 01 Jul 2016 Results published in the British Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top